0102030405
CAS No 1799733-69-9 VOXILAPREVIR INT Pharmaceutical Intermediates
02
VOXILAPREVIR INT PROFILE
VOXILAPREVIR INT PROFILE
VOXILAPREVIR INT is a novel antiviral medicine that plays a vital role in the treatment of hepatitis C virus (HCV) infection. As part of the direct-acting antiviral (DAA) class of medicines, VOXILAPREVIR INT is designed to inhibit viral replication, making it an important component of HCV combination therapy. Our VOXILAPREVIR INT is manufactured under strict quality control measures to ensure that it meets the highest standards required for pharmaceutical use.
02
product detail
|
Product name |
VOXILAPREVIR INT |
|
CAS No. |
1799733-69-9 |
|
EINECS |
/ |
|
Formula |
C26H33F2N3O6 |
|
Molecular Weight |
521.55 |
|
Appearance |
white to off-white crystalline powder |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
VOXILAPREVIR INT possesses several key physical and chemical properties that determine its effectiveness and usability in pharmaceutical formulations:
-Molecular formula: C26H33F2N3O6
-Molecular weight: 521.55 g/mol
-Appearance: VOXILAPREVIR INT is usually a white to off-white crystalline powder that is easy to handle and incorporate into a variety of formulations.
-Solubility: It is soluble in organic solvents and has moderate solubility in water, enhancing its versatility in different pharmaceutical applications.
-Stability: VOXILAPREVIR INT is stable under standard storage conditions, ensuring its reliability for long-term use in pharmaceutical products.
VOXILAPREVIR INT offers many advantages in pharmaceutical applications:
1.Therapeutic effect: VOXILAPREVIR INT can effectively inhibit the replication of hepatitis C virus, providing a key option for patients receiving treatment.
2.Broad-spectrum activity: As part of combination therapy, VOXILAPREVIR INT can be used with other antiviral drugs to enhance treatment efficacy and improve patient outcomes.
3.Cost-effective: Our integrated production and trading model enables us to offer competitive prices without compromising quality, making VOXILAPREVIR INT an economical choice for pharmaceutical manufacturers.
4.Reliable supply chain: As a factory with both production and trading capabilities, we ensure a stable supply of VOXILAPREVIR INT and minimize interruptions in the production process.
VOXILAPREVIR INT is primarily used in the pharmaceutical industry to treat hepatitis C virus infection. Its unique chemical properties make it ideal for the treatment of:
-Formulation Development: VOXILAPREVIR INT is formulated into tablets and other dosage forms, allowing for flexible dosing options based on patient needs.
-Research and Development: Pharmaceutical researchers are using VOXILAPREVIR INT to explore its efficacy and safety in clinical studies to contribute to the advancement of hepatitis C treatment.
-Custom Synthesis: Our facilities are capable of processing custom synthesis requests, allowing customers to receive tailor-made solutions to meet their specific needs.
In conclusion, VOXILAPREVIR INT is an important compound for the pharmaceutical industry, known for its high purity, efficacy, and broad activity against hepatitis C virus infection. As a factory integrating production and trading, we are committed to providing customers with the highest quality products and reliable services. Choose us for your chemical needs and experience the difference in quality and support. Contact us today to learn more about our products and how we can help your pharmaceutical business.
By choosing our VOXILAPREVIR INT, you are not only ensuring optimal results for your formulation, but you are also working with a trusted manufacturer committed to excellence in the pharmaceutical industry.